Prostate Cancer
Daily online bony correction is required for prostate patients without fiducial markers or soft-tissue imaging - Abstract
April 28, 2011
Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1 - Abstract
April 28, 2011
EAU 2011 - A negative multi-parametric MRI can rule out up to 97% of clinically significant prostate cancer - Session Highlights
April 28, 2011
High-risk prostate cancer: The role of radical prostatectomy for local therapy - Abstract
April 27, 2011
Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells - Abstract
April 27, 2011
Inguinal hernia after radical retropubic prostatectomy: Risk factors and prevention - Abstract
April 27, 2011
Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaidTM: Mechanism of activity - Abstract
April 27, 2011
New prostate cancer test gives more accurate diagnosis
April 27, 2011
EAU 2011 - Cosmetic outcome after radical prostatectomy: A patient’s preference survey - Session Highlights
April 27, 2011